Alignment Healthcare (NASDAQ: ALHC) reaffirms 4-Star Medicare Advantage membership outlook

Rhea-AI Filing Summary

Alignment Healthcare, Inc. is meeting with investors and analysts on September 9–10, 2025 to discuss its business strategy, competitive position in the Medicare Advantage market, and recent operating results. The company also plans to review preliminary Centers for Medicare & Medicaid Services Medicare Advantage Star ratings for rating year 2026 and payment year 2027.

Based on an early look at the data, Alignment Healthcare will reaffirm its expectation that approximately 100% of its membership will be enrolled in plans rated 4 Stars or higher, which is an important quality benchmark in Medicare Advantage. The company reminds readers that this expectation is forward-looking and subject to risks, including its ability to maintain high Star ratings, navigate regulatory requirements, manage provider relationships, and address labor and other operational challenges.

0001832466FALSE00018324662025-09-092025-09-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 9, 2025

_______________________________

ALIGNMENT HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware			001-40295			46-5596242
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

1100 W. Town and Country Road, Suite 1600

Orange, California 92868

(Address of Principal Executive Offices) (Zip Code)

(844) 310-2247

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.001 per share			ALHC			The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 7.01 Regulation FD Disclosure.

Senior leaders from Alignment Healthcare, Inc. (the "Company") are meeting with investors and analysts between September 9, 2025 and September 10, 2025, during which the Company intends to discuss its strategy, market position and recent results. The Company will also discuss preliminary Centers for Medicare & Medicaid Services (CMS) Medicare Advantage Star ratings for rating year 2026 / payment year 2027. While the related data is still under evaluation, based on a preliminary review, the Company will reaffirm its expectation that approximately 100% of its membership will be in 4 Star or higher plans.

Cautionary Statement

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the Company's ability to attract new members and enter new markets, including the need for certain governmental approvals; its ability to maintain a high rating for its plans on the Five Star Quality Rating System; its ability to develop and maintain satisfactory relationships with care providers that service its members; risks associated with being a government contractor; changes in laws and regulations applicable to its business model; risks related to its indebtedness; changes in market or industry conditions and receptivity to its technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in its labor costs. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in its Annual Report on Form 10-K for the year ended December 31, 2024, and the other periodic reports it files with the SEC. All information provided in this Current Report on Form 8-K is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law.

The information in this Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Alignment Healthcare, Inc.
Date: September 9, 2025			By:			/s/ Christopher Joyce
						Christopher Joyce
						Chief Legal & Administrative Officer

FAQ

What did Alignment Healthcare (ALHC) disclose in this 8-K?

Alignment Healthcare reported that senior leaders are meeting with investors and analysts on September 9–10, 2025 to discuss strategy, market position, recent results, and preliminary Medicare Advantage Star ratings for rating year 2026 and payment year 2027.

What is Alignment Healthcare (ALHC) saying about its Medicare Advantage Star ratings?

The company will discuss preliminary CMS Medicare Advantage Star ratings and will reaffirm its expectation that approximately 100% of its membership will be in plans rated 4 Stars or higher for rating year 2026 / payment year 2027, based on a preliminary review of data still under evaluation.

Are the Medicare Advantage Star ratings for Alignment Healthcare final?

No. The company states that the related data is still under evaluation and that its expectation about 100% of membership in 4 Star or higher plans is based on a preliminary review of the information.

Does this 8-K include detailed financial results for Alignment Healthcare (ALHC)?

No. The disclosure focuses on upcoming meetings with investors and analysts and discussion topics, including strategy, market position, recent results, and preliminary Medicare Advantage Star ratings, rather than providing detailed financial statements.

How does Alignment Healthcare describe the risks around its forward-looking statements?

The company notes that forward-looking statements are subject to risks and uncertainties, including its ability to attract new members, maintain high Star ratings, secure governmental approvals, manage provider relationships, comply with changing laws and regulations, handle indebtedness, respond to industry conditions, address litigation or security incidents, and deal with shortages of qualified personnel.

Is the information in this Alignment Healthcare 8-K considered filed with the SEC?

The company states that the information in Item 7.01 is not deemed “filed” for purposes of Section 18 of the Exchange Act, is not subject to the liabilities of that section, and will not be incorporated by reference into Securities Act or Exchange Act filings unless specifically referenced.